Insider Transactions last 24 months for Aclaris Therapeutics, Inc.  -  NSDQ: ACRS

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Molineaux Christopher P.Director06/06/2025AMDirectCOM4,793$0.00$0.0057,956
Gowen MaxineDirector06/06/2025AMDirectCOM4,793$0.00$0.0021,754
Humphries William D.Director06/06/2025AMDirectCOM4,793$0.00$0.0033,525
Mehra AnandDirector06/06/2025AMDirectCOM4,793$0.00$0.00714,823
Milano VincentDirector06/06/2025AMDirectCOM4,793$0.00$0.0017,316
Schiff Andrew NDirector06/06/2025AMDirectCOM4,793$0.00$0.0013,960
Walker NealCEO05/01/2025DFDirectCOM2,975$1.38$4,105.501,479,824
Walker NealCEO05/01/2025AMDirectCOM9,467$0.00$0.001,482,799
Walker NealCEO04/01/2025DFDirectCOM3,042$1.48$4,502.161,473,332
Walker NealCEO04/01/2025AMDirectCOM9,467$0.00$0.001,476,374
Balthaser KevinChief Financial Officer03/01/2025DFDirectCOM727$1.99$1,446.7392,608
Balthaser KevinChief Financial Officer03/01/2025AMDirectCOM2,375$0.00$0.0093,335
Balthaser KevinChief Financial Officer03/01/2025AMDirectCOM1,100$0.00$0.0090,960
Monahan JosephChief Scientific Officer03/01/2025DFDirectCOM27,258$1.99$54,243.42265,662
Monahan JosephChief Scientific Officer03/01/2025AMDirectCOM10,925$0.00$0.00292,920
Monahan JosephChief Scientific Officer03/01/2025AMDirectCOM50,000$0.00$0.00281,995
Walker NealCEO03/01/2025DFDirectCOM3,277$1.99$6,521.231,466,907
Walker NealCEO03/01/2025AMDirectCOM9,466$0.00$0.001,470,184
Loerop JamesChief Business Officer02/01/2025DFDirectCOM15,447$2.48$38,308.56103,306
Loerop JamesChief Business Officer02/01/2025AMDirectCOM14,750$0.00$0.00118,753
Loerop JamesChief Business Officer02/01/2025AMDirectCOM7,500$0.00$0.00104,003
Loerop JamesChief Business Officer02/01/2025AMDirectCOM11,250$0.00$0.0096,503
Balthaser KevinChief Financial Officer02/01/2025DFDirectCOM5,816$2.48$14,423.6889,860
Balthaser KevinChief Financial Officer02/01/2025AMDirectCOM14,750$0.00$0.0095,676
Monahan JosephChief Scientific Officer02/01/2025DFDirectCOM11,317$2.48$28,066.16231,995
1   2  3  4  5  Next Last  You are at page 1 of 5 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel